—

GlaxoSmithKline PLC ADR(GSK)— 同类公司组

数据截至2026-09-24 — 评分每个交易日晚间重新计算。分组标准=首先为共同的Closelook指数成分,其次为行业。Closelook研究日记,不构成投资建议。

GlaxoSmithKline PLC ADR的Closelook综合评分为53/100,在同类公司组内排名第9位(共11家)——组内评分最高的是Halozyme Therapeutics Inc(74/100)。

名称综合动量质量估值信号距52周高点
GSK GlaxoSmithKline PLC ADR53347958info17.4%
LLY Eli Lilly and Company64719128watch11%
SAN.PA Sanofi SA56356861watch15.3%
NVO Novo Nordisk A/S55308674bear38.3%
AMGN Amgen Inc54718443bull9.2%
GRF.MC Grifols S.A.48444380info26.4%
VIRP.PA Virbac SA48245461warn22.1%
HALO Halozyme Therapeutics Inc74969445ok1.4%
DXCM DexCom Inc66858036neutral5.2%
ARGX argenx NV ADR64747327ok10.3%
ONC BeiGene, Ltd.64796332ok6.6%

评分为Closelook全部覆盖范围内的相对读数——方法论见公司评分说明。信号灯来自每日夜间信号看板。

FAQ · from the current data · as of 2026-09-24

Quick answers

GlaxoSmithKline PLC ADR在Closelook覆盖范围内的同类公司有哪些?

分组首先基于共同的Closelook指数成分,其次基于行业:Eli Lilly and Company (LLY)、Sanofi SA (SAN.PA)、Novo Nordisk A/S (NVO)、Amgen Inc (AMGN)、Grifols S.A. (GRF.MC)、Virbac SA (VIRP.PA)、Halozyme Therapeutics Inc (HALO)、DexCom Inc (DXCM)等。

GSK相对同类公司的评分如何?

GlaxoSmithKline PLC ADR的综合评分为53/100,组内排名第9位(共11家),截至2026-09-24;组内最高综合评分为Halozyme Therapeutics Inc(74/100)。Closelook评分为研究日记读数,不构成评级或投资建议。

Related in the Closelook universe

then Drug Manufacturers - General, then Healthcare. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.